Current Report Filing (8-k)
March 14 2017 - 4:07PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant
to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): March 14, 2017
IGNYTA, INC.
(Exact
Name of Registrant as Specified in its Charter)
|
|
|
|
|
Delaware
|
|
001-36344
|
|
45-3174872
|
(State of Incorporation)
|
|
(Commission
File Number)
|
|
(IRS Employer
Identification No.)
|
4545 Towne Centre Court
San Diego, California 92121
(Address of principal executive offices, including zip code)
Registrants telephone number, including area code: (858) 255-5959
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:
☐
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
☐
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
☐
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
☐
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Item 2.02.
|
Results of Operations and Financial Condition
|
On March 14, 2017, Ignyta, Inc. issued a press
release announcing its results of operations for the year ended December 31, 2016. The full text of such press release is furnished as Exhibit 99.1 to this report.
In accordance with General Instruction B.2. of Form 8-K, the information in this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed
filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the Exchange Act), or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference in any
filing under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date hereof, except as expressly set forth by specific reference in such filing to this Current Report on Form 8-K.
Item 9.01.
|
Financial Statements and Exhibits
|
(d)
Exhibits
.
The following press release is furnished as an exhibit to this Current Report on Form 8-K pursuant to Item 2.02 and shall not be deemed to be
filed:
|
|
|
Exhibit No.
|
|
Description
|
|
|
99.1
|
|
Press Release, dated March 14, 2017.
|
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized.
|
|
|
|
|
|
|
Dated: March 14, 2017
|
|
|
|
IGNYTA, INC.
|
|
|
|
|
|
|
|
|
By:
|
|
/s/ Jonathan E. Lim, M.D.
|
|
|
|
|
Name: Jonathan E. Lim, M.D.
|
|
|
|
|
Title: President and Chief Executive Officer
|
EXHIBIT INDEX
|
|
|
Exhibit
Number
|
|
Description of Exhibit
|
|
|
99.1
|
|
Press Release, dated March 14, 2017
|
Prometheus Biosciences (NASDAQ:RXDX)
Historical Stock Chart
From Apr 2024 to May 2024
Prometheus Biosciences (NASDAQ:RXDX)
Historical Stock Chart
From May 2023 to May 2024